Kiniksa Pharmaceuticals International (KNSA) Gross Margin (2021 - 2026)
Kiniksa Pharmaceuticals International's Gross Margin came in at 90.32% for Q2 2026, up 2.19 percentage points from 88.14% a year earlier and up 0.03 percentage points from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) Gross Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kiniksa Pharmaceuticals International reported Gross Margin of 89.82%, up 3.89 percentage points year-over-year; for FY2025, it came in at 88.54%, up 2.93 percentage points from FY2024.
- Gross Margin carries a four-year change of +12.15 percentage points (FY2021 to FY2025).
- Going back by year, Gross Margin was 85.61% in FY2024 (-2.03 pp), 87.64% in FY2023 (-1.96 pp), 89.60% in FY2022 (+13.21 pp) and 76.39% in FY2021.
- The Q2 2026 figure represents the highest quarterly Gross Margin since Q3 2022.
- Year-over-year, Gross Margin has increased for four consecutive quarters, with an average year-over-year change of +1.09 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q3 2022 (a gain of 15.88 percentage points), and the weakest in Q3 2023 (a drop of 6.56 percentage points).
- Business Quant data shows KNSA's Gross Margin at 90.29% (Q1 2026), 89.64% (Q4 2025) and 88.80% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 90.32% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.32% |
| Mar 31, 2026 | 90.29% |
| Dec 31, 2025 | 89.64% |
| Sep 30, 2025 | 88.80% |
| Jun 30, 2025 | 88.14% |
| Mar 31, 2025 | 87.03% |
| Dec 31, 2024 | 85.40% |
| Sep 30, 2024 | 82.08% |
| Jun 30, 2024 | 88.66% |
| Mar 31, 2024 | 86.75% |
| Dec 31, 2023 | 88.51% |
| Sep 30, 2023 | 86.45% |
| Jun 30, 2023 | 89.23% |
| Mar 31, 2023 | 85.45% |
| Dec 31, 2022 | 89.16% |
| Sep 30, 2022 | 93.00% |
| Jun 30, 2022 | 81.35% |
| Mar 31, 2022 | 86.89% |
| Dec 31, 2021 | 79.37% |
| Sep 30, 2021 | 77.12% |
Kiniksa Pharmaceuticals International Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();